Oragenics Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: Feb 5, 2025 · CIK: 1174940
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Oragenics filed an 8-K on Feb 5, 2025, likely with financial updates. Check for details.
AI Summary
On February 5, 2025, Oragenics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and other significant occurrences. No specific financial figures or new events were detailed in the provided excerpt.
Why It Matters
This filing signals that Oragenics, Inc. has made a regulatory disclosure, potentially containing important updates for investors regarding financial statements or other material events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K disclosure without immediate indication of significant financial distress or major operational changes.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- February 5, 2025 (date) — Date of earliest event reported
FAQ
What specific "Other Events" are being reported by Oragenics, Inc. in this 8-K filing?
The provided excerpt does not detail the specific "Other Events" being reported, only that this item is included in the filing.
What "Financial Statements and Exhibits" are included with this 8-K filing?
The excerpt states that "Financial Statements and Exhibits" are part of the filing, but does not list their specific contents.
What is the principal executive office address for Oragenics, Inc.?
The principal executive offices of Oragenics, Inc. are located at 1990 Main Street, Suite 750, Sarasota, FL 34236.
What is the telephone number for Oragenics, Inc.?
The telephone number for Oragenics, Inc. is 813-286-7900.
What is the SIC code for Oragenics, Inc.?
The Standard Industrial Classification (SIC) code for Oragenics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 445 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2025-02-05 08:00:12
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 10KB
- 0001493152-25-004946.txt ( ) — 226KB
- ogen-20250205.xsd (EX-101.SCH) — 3KB
- ogen-20250205_lab.xml (EX-101.LAB) — 33KB
- ogen-20250205_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 5 th day of February 2025. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer